← k3vl4r
Log inGet started →

ARQT (Arcutis Biotherapeutics Inc) Price Forecast

AI-generated price forecast for Arcutis Biotherapeutics Inc (ARQT) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's calibrated AI forecast currently reads ARQT as 1/1 bullish across its horizons (1 of 1 timeframes pointing up), with a last price of 29.06. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

29.06

AI outlook

1/1 bullish

Timeframes up

1 / 1

Share𝕏PostTelegram

ARQT forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▲ Up+16.10%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called ARQT's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest ARQT news

From the market-news feed the forecasts are read against.

  • Cantor Fitzgerald Initiates Coverage On Arcutis Biotherapeutics with Overweight Rating, Announces Price Target of $48 · Benzinga · Oct 15
  • 2 Stocks That Could Soar in Q4 · Yahoo · Oct 12
  • Arcutis Biotherapeutics (ARQT) Showcased Fresh ZORYVE Data, Is It Still 28% Below Fair Value? · Yahoo · Oct 10
  • Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Jumps 7% - Should You Buy? · ldr:marketbeat.com · Oct 9
  • Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical · Yahoo · Oct 9

🔒

See the full ARQT forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

ARQT forecast — frequently asked

Will ARQT go up?

K3vl4r's calibrated AI forecast currently reads ARQT as 1/1 bullish — 1 of 1 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the ARQT price prediction for 2026?

K3vl4r's model projects ARQT toward $33.79 over the next ~4 weeks, a +16.1% move from $29.10. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

LGVNCGEMPHATSNDALXRXSLSCDXSCOOBKDIRONEHCSENSIPSCCTXR

Will ARQT reach…?

Will ARQT reach $50.00?Will ARQT reach $100.00?Will ARQT reach $200.00?

Or see the full ARQT price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare ARQT

ARQT vs LGVNARQT vs CGEMARQT vs PHATARQT vs SNDAARQT vs LXRXARQT vs SLS

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.